Alpine Woods Capital Investors’s Endologix Inc ELGX Stock Holding History

Alpine Woods Capital Investors’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1,000	Closed	-$174K	–	469
2013 Q4	$174K	Hold	1,000	–	–	0.01%	391
2013 Q3	$161K	Hold	1,000	–	–	0.01%	348
2013 Q2	$132K	Buy	+1,000	New	+$141K	0.01%	334

Other funds holding ELGX

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Alpine Woods Capital Investors's ELGX Position: Q1 2014 in Review

Alpine Woods Capital Investors sold out of Endologix Inc (ELGX) in Q1 2014, closing a stake of 1,000 shares — an estimated $174K sold.

Alpine Woods Capital Investors first reported a position in ELGX in Q2 2013 and held it in 3 quarters. The position peaked at $174K in Q4 2013. 129 funds tracked by Wall St. Rank hold ELGX as of Q1 2014.

Alpine Woods Capital Investors reported no remaining Endologix Inc position as of Q1 2014 after selling out during the quarter.
Alpine Woods Capital Investors sold 1,000 Endologix Inc shares in Q1 2014, an estimated $174K.
Alpine Woods Capital Investors first reported a position in Endologix Inc in Q2 2013 and held it in 3 quarters.
Alpine Woods Capital Investors's Endologix Inc position peaked at $174K in Q4 2013.
129 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2014.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2014, filed 12 May 2014.